Lung / Esophageal / Thoracic Cancer Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Esophagus Clinical Trials
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
Esophagus
R0436
Hartford
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Esophagus
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Esophagus
FED11061
Pace
Lung Clinical Trials
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB - IIIA Non-Small Cell Lung Cancer (NSCLC)
Lung
E1505
Larmon
A Randomized Phase III Double-Blind Trial Evaluating Selective COX-2 Inhibition In COX-2 Expressing Advanced Non-Small Cell Lung Cancer
Lung
C30801
Dragnev
A Randomized, Double-Blind, Placebo-Controlled Phase III Study of First-Line Maintenance Tarceva vs Tarceva at the Time of Disease Progression in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following 4 Cycles of Platinum-Based Chemotherapy
Lung
F11177
Rigas
A Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500ug Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy (20070782)
Lung
F11035
Kuemmerle
An Open-Label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Lung
F12185
Rigas
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Lung
D0946
Bakitas
Phase 3, Randomized, Open-Label Study of the Efficacy and Safety of Crizotinib versus Pemetrexed/Cisplatin or Pemetrexed/Carboplatin in Previously Untreated Patients with Non-squamous Carcinoma of the Lung Harboring a Translocation or Inversion Event Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus
Lung
F1057
Dragnev
Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis - Related Pain During the Treatment of Lung Cancer
Lung
R1012
Hartford
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer
Lung
D1026
Rigas
Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects with Stage IV/Recurrent Non-Small Cell Lung Cancer (NSCLC)
Lung
F11054
Rigas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Lung
FED11061
Pace
Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients
Lung
R0813
Hartford
Other Respiratory and Intrathoracic Organs Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Respiratory and Intrathoracic Organs
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Respiratory and Intrathoracic Organs
FED11061
Pace
